Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Vishvarani, Wanigasekera"'
Autor:
Caterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Nanna Brix Finnerup, Luis Garcia-Larrea, Tom Li, Marcus Goetz, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Irene Tracey, Inaki F. Troconiz, Hans Van Niel, Jose Miguel Vela Hernandez, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Andrea Truini, Rolf-Detlef Treede
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-26 (2022)
Abstract Background IMI2-PainCare-BioPain-RCT2 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on specific compartments of the nociceptive system that could serve to accelerate the
Externí odkaz:
https://doaj.org/article/ee7c96a2132b40cebc8ecb1b9816874f
Autor:
Zahra Nochi, Hossein Pia, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Francesca Fardo, Bernd Genser, Marcus Goetz, Anna V. Kostenko, Caterina Leone, Thomas Li, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Alexandre Stouffs, Irene Tracey, Iñaki F. Troconiz, Andrea Truini, Johannes Van Niel, Jose Miguel Vela, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Hatice Tankisi, Nanna B. Finnerup, Keith G. Phillips, Rolf-Detlef Treede
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-20 (2022)
Abstract Background Few new drugs have been developed for chronic pain. Drug development is challenged by uncertainty about whether the drug engages the human target sufficiently to have a meaningful pharmacodynamic effect. IMI2-PainCare-BioPain-RCT1
Externí odkaz:
https://doaj.org/article/543fb202ce1b43b69a2ff64278b428c1
Autor:
André Mouraux, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Giulia Di Stefano, Nanna Brix Finnerup, Luis Garcia-Larrea, Marcus Goetz, Anna Kostenko, Bernhard Pelz, Esther Pogatzki-Zahn, Karin Schubart, Alexandre Stouffs, Andrea Truini, Irene Tracey, Iñaki F. Troconiz, Johannes Van Niel, Jose Miguel Vela, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Rolf-Detlef Treede
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-31 (2021)
Abstract Background IMI2-PainCare-BioPain-RCT3 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on the nociceptive system that could serve to accelerate the future development of an
Externí odkaz:
https://doaj.org/article/dbc3721db98f4427b854c0fc14ee978d
Autor:
Sarah Waldman, Vishvarani Wanigasekera, Julia Henrich, Maryanne Martin, Bergljot Gjelsvik, Irene Tracey
Publikováno v:
British Journal of Surgery. 109
Aims Chronic visceral pain can cause repeated presentations to surgical services. Cognitive therapies show promise but are not often considered in the surgical setting. This study aims to assess the efficacy and mechanisms of MBCT-IBS, a mindfulness-
Autor:
Naiduwa W. I. L Silva, Anushka Soni, Vishvarani Wanigasekera, Suyi Zhang, Amanda J. W Wall, Irene Tracey
Publikováno v:
Rheumatology. 61
Background/Aims Sleep problems are common in fibromyalgia (FM) and chronic widespread pain (CWP), and may result in similar structural brain changes as those seen in chronic pain. However, the exact neural mechanisms are not fully understood. Studies
Autor:
Caterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Nanna Brix Finnerup, Luis Garcia-Larrea, Tom Li, Marcus Goetz, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Irene Tracey, Inaki F. Troconiz, Hans Van Niel, Jose Miguel Vela Hernandez, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Andrea Truini, Rolf-Detlef Treede
Publikováno v:
Leone, C, Di Stefano, G, Di Pietro, G, Bloms-Funke, P, Boesl, I, Caspani, O, Chapman, S C, Finnerup, N B, Garcia-Larrea, L, Li, T, Goetz, M, Mouraux, A, Pelz, B, Pogatzki-Zahn, E, Schilder, A, Schnetter, E, Schubart, K, Tracey, I, Troconiz, I F, Van Niel, H, Hernandez, J M V, Vincent, K, Vollert, J, Wanigasekera, V, Wittayer, M, Phillips, K G, Truini, A & Treede, R D 2022, ' IMI2-PainCare-BioPain-RCT2 protocol : a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity ', Trials, vol. 23, no. 1, 739 . https://doi.org/10.1186/s13063-022-06431-5
Background IMI2-PainCare-BioPain-RCT2 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on specific compartments of the nociceptive system that could serve to accelerate the future d
Autor:
Katy Vincent, Marcus Goetz, Irene Tracey, Alexandre Stouffs, Matthias Wittayer, Giulia Di Stefano, Rolf-Detlef Treede, André Mouraux, Andrea Truini, Jose Miguel Vela, Esther M. Pogatzki-Zahn, Luis Garcia-Larrea, Johannes Van Niel, Irmgard Boesl, Anna Kostenko, Keith G. Phillips, Petra Bloms-Funke, Ombretta Caspani, Bernhard Pelz, Karin Schubart, Vishvarani Wanigasekera, Sonya C. Chapman, Iñaki F. Trocóniz, Nanna B. Finnerup, Jan Vollert
Publikováno v:
Trials
Mouraux, A, Bloms-Funke, P, Boesl, I, Caspani, O, Chapman, S C, Di Stefano, G, Finnerup, N B, Garcia-Larrea, L, Goetz, M, Kostenko, A, Pelz, B, Pogatzki-Zahn, E, Schubart, K, Stouffs, A, Truini, A, Tracey, I, Troconiz, I F, Van Niel, J, Vela, J M, Vincent, K, Vollert, J, Wanigasekera, V, Wittayer, M, Phillips, K G & Treede, R D 2021, ' IMI2-PainCare-BioPain-RCT3 : a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG) ', Trials, vol. 22, 404 . https://doi.org/10.1186/s13063-021-05272-y
Trials, Vol 22, Iss 1, Pp 1-31 (2021)
Mouraux, A, Bloms-Funke, P, Boesl, I, Caspani, O, Chapman, S C, Di Stefano, G, Finnerup, N B, Garcia-Larrea, L, Goetz, M, Kostenko, A, Pelz, B, Pogatzki-Zahn, E, Schubart, K, Stouffs, A, Truini, A, Tracey, I, Troconiz, I F, Van Niel, J, Vela, J M, Vincent, K, Vollert, J, Wanigasekera, V, Wittayer, M, Phillips, K G & Treede, R D 2021, ' IMI2-PainCare-BioPain-RCT3 : a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG) ', Trials, vol. 22, 404 . https://doi.org/10.1186/s13063-021-05272-y
Trials, Vol 22, Iss 1, Pp 1-31 (2021)
Background IMI2-PainCare-BioPain-RCT3 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on the nociceptive system that could serve to accelerate the future development of analgesics,
Autor:
Barbara Hoggart, Natalie Massat, Eugene P. Duff, William Vennart, Vishvarani Wanigasekera, Irene Tracey, Karolina Wartolowska, John P. Huggins, Mark Whitlock, Lynne Pauer, Peter Rogers
Publikováno v:
British Journal of Anaesthesia. 123:e166-e171
Autor:
Jet Bussemaker, Ben Colagiuri, Winfried Rief, Lauren Y. Atlas, Andrew L. Geers, Tor D. Wager, Luana Colloca, Vishvarani Wanigasekera, Irving Kirsch, Vitaly Napadow, Lene Vase, Alia J. Crum, Jens Gaab, Karin Meissner, Keith J. Petrie, John M. Kelley, Jeremy Howick, Ulrike Bingel, Stefanie H Meeuwis, Andrea W M Evers, Regine Klinger, Chris Beedie, Fabrizio Benedetti, Damien G Finniss, Christian Büchel, Karin B. Jensen, Charlotte Blease, Ionica Smeets
Publikováno v:
Evers, A W M, Colloca, L, Blease, C, Gaab, J, Jensen, K B, Atlas, L Y, Beedie, C J, Benedetti, F, Bingel, U, Büchel, C, Bussemaker, J, Colagiuri, B, Crum, A J, Finniss, D G, Geers, A L, Howick, J, Klinger, R, Meeuwis, S H, Meissner, K, Napadow, V, Petrie, K J, Rief, W, Smeets, I, Wager, T D, Wanigasekera, V, Vase, L, Kelley, J M & Kirsch, I 2021, ' "Consensus on Placebo and Nocebo Effects Connects Science with Practice" : Reply to "Questioning the Consensus on Placebo and Nocebo Effects" ', Psychotherapy and Psychosomatics, vol. 90, no. 3, pp. 213-214 . https://doi.org/10.1159/000514435
Psychotherapy and Psychosomatics, 90(3), 213-214. S. Karger AG
Psychotherapy and Psychosomatics, 90(3)
Psychotherapy and Psychosomatics, 90(3), 213-214. S. Karger AG
Psychotherapy and Psychosomatics, 90(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76524ab2104405777ba9935b570cf7b
https://hdl.handle.net/1887/3256800
https://hdl.handle.net/1887/3256800
Autor:
Christian Büchel, Stefanie H Meeuwis, Tor D. Wager, Chris Beedie, John M. Kelley, Fabrizio Benedetti, Jeremy Howick, Jet Bussemaker, Karin B. Jensen, Keith J. Petrie, Ulrike Bingel, Lene Vase, Vishvarani Wanigasekera, Vitaly Napadow, Karin Meissner, Irving Kirsch, Jens Gaab, Damien G Finniss, Alia J. Crum, Winfried Rief, Andrew L. Geers, Ben Colagiuri, Lauren Y. Atlas, Andrea W M Evers, Regine Klinger, Luana Colloca, Charlotte Blease, Ionica Smeets
Publikováno v:
Psychotherapy and Psychosomatics, 90(1), 49-56. S. Karger AG
Evers, A W M, Colloca, L, Blease, C, Gaab, J, Jensen, K B, Atlas, L Y, Beedie, C J, Benedetti, F, Bingel, U, Büchel, C, Bussemaker, J, Colagiuri, B, Crum, A J, Finniss, D G, Geers, A L, Howick, J, Klinger, R, Meeuwis, S H, Meissner, K, Napadow, V, Petrie, K J, Rief, W, Smeets, I, Wager, T D, Wanigasekera, V, Vase, L, Kelley, J M, Kirsch, I & Consortium of Placebo Experts 2020, ' What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus ', Psychotherapy and Psychosomatics, vol. 90, no. 1, pp. 49-56 . https://doi.org/10.1159/000510738
Psychotherapy and Psychosomatics, 90 (2021)(1)
Psychotherapy and Psychosomatics, 90(1), 49-56. KARGER
Psychotherapy and Psychosomatics, 90(1), 49-56
Evers, A W M, Colloca, L, Blease, C, Gaab, J, Jensen, K B, Atlas, L Y, Beedie, C J, Benedetti, F, Bingel, U, Büchel, C, Bussemaker, J, Colagiuri, B, Crum, A J, Finniss, D G, Geers, A L, Howick, J, Klinger, R, Meeuwis, S H, Meissner, K, Napadow, V, Petrie, K J, Rief, W, Smeets, I, Wager, T D, Wanigasekera, V, Vase, L, Kelley, J M, Kirsch, I & Consortium of Placebo Experts 2020, ' What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus ', Psychotherapy and Psychosomatics, vol. 90, no. 1, pp. 49-56 . https://doi.org/10.1159/000510738
Psychotherapy and Psychosomatics, 90 (2021)(1)
Psychotherapy and Psychosomatics, 90(1), 49-56. KARGER
Psychotherapy and Psychosomatics, 90(1), 49-56
Introduction: Clinical and laboratory studies demonstrate that placebo and nocebo effects influence various symptoms and conditions after the administration of both inert and active treatments. Objective: There is an increasing need for up-to-date re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa83d67b9f9b6935951bdd6caa07473a
http://hdl.handle.net/1887/3256802
http://hdl.handle.net/1887/3256802